Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Sequential Measurements of Insulin Resistance (IR) in the Assessment of Individuals Participating In Diabetes Prevention Programs

WCIRDC 2024

World Congress Insulin Resistance & Cardiovascular Disease

Universal City, CA,  Dec 12-14, 2024

Poster presentation: Sequential Measurements of Insulin Resistance (IR) in the Assessment of Individuals Participating In Diabetes Prevention Programs

Authors: Brandon M, Larsen J, McPhaul MJ

Specialty: Cardiology, Endocrinology

Related content

Audio Podcast
Action From Insight: Tackling Insulin Resistance
Publication
Impact of a Digital Diabetes Prevention Program on Risk factors for Chronic Disease in a Workforce Cohort
Conference Presentation
Measures of Insulin Resistance (IR) Increase with Increasing BMI in a Population of Normoglycemic Working Adults
Publication
Insulin Resistance Probability Score and Incident Cardiovascular Disease
Test FAQ
Insulin Intact LC MS MS
Conference Presentation
Participants in Annual Workplace Health Evaluation Program had Lower Risk for Developing Diabetes
Publication
An Insulin Resistance Score Improved Diabetes Risk Assessment in the Malmö Prevention Project-A Longitudinal Population-Based Study of Older European
Conference Presentation
Insulin resistance probability score and cardiovascular events in the elderly
Conference Presentation
The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.